← Back to Clinical Trials
Recruiting NCT07370714

NCT07370714 Factors Affecting Wound Dehiscence in Pilonidal Sinus Surgery (ORIPIS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07370714
Status Recruiting
Phase
Sponsor Ankara Etlik City Hospital
Condition Pilonidal Sinus Disorder
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2025-12-01
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
No intervention (observational study)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2025-12-01 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this multicenter, prospective, observational study is to investigate factors associated with wound dehiscence following pilonidal sinus surgery. The main questions it aims to answer are: Does the proximity of the pilonidal sinus to the anal verge influence the risk of postoperative wound dehiscence? How do the morphological stage of the disease and the surgical technique used affect wound healing outcomes? Patients undergoing pilonidal sinus surgery as part of routine clinical care will be enrolled prospectively across multiple centers. Clinical, anatomical, and surgical characteristics-including anal proximity, morphological stage, and type of surgical technique-will be recorded. Participants will be followed postoperatively, and wound outcomes will be assessed to identify factors associated with wound dehiscence.

Eligibility Criteria

Inclusion Criteria: * Adult patients (≥18 years of age) * Diagnosis of pilonidal sinus disease * Patients undergoing pilonidal sinus surgery as part of routine clinical care * Ability to provide informed consent Exclusion Criteria: * Patients undergoing emergency surgery * Previous pilonidal sinus surgery at the same site * Inability to complete postoperative follow-up

Contact & Investigator

Central Contact

Muhammed Salih Süer, Attendant

✉ suersalih@gmail.com

📞 +905445943494

Frequently Asked Questions

Who can join the NCT07370714 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Pilonidal Sinus Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07370714 currently recruiting?

Yes, NCT07370714 is actively recruiting participants. Contact the research team at suersalih@gmail.com for enrollment information.

Where is the NCT07370714 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07370714 clinical trial?

NCT07370714 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology